Table 2.
Biomedical Factors Associated With CGM Use at 6 Months.
| CGM use |
P | |||
|---|---|---|---|---|
| 0-5 days/week (n = 39) | 6-7 days/week (n = 22) | |||
| Sex (% male) | 56 | 45 | .4 | |
| Age (years) | 13.4 ± 3.0 | 12.9 ± 2.8 | .4 | |
| Diabetes duration (years) | 7.1 ± 3.9 | 6.5 ± 3.6 | .6 | |
| Insulin dose (U/kg/day) | 0.95 ± 0.25 | 0.89 ± 0.27 | .2 | |
| Insulin regimen (% pump users) | 85 | 91 | .7 | |
| Blood glucose monitoring (%) | 0-4 times/day | 21 | 18 | .05 |
| 5-7 times/day | 59 | 32 | ||
| ≥8 times/day | 21 | 50 | ||
| Missing insulin doses (% yes) | 47 | 18 | .02 | |
| A1c <7.5% (ADA target) (%) | 26 | 59 | .01 | |
Data are mean ± SD or %. Biomedical variables are from the 6-month visit. A1c, hemoglobin A1c.